Andere talen Nightingale Health Oyj

Aandelen

HEALTH

FI4000490875

Vertraagde tijd Nasdaq Helsinki Andere beurzen 17:29:41 20-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
1,59 ^EUR	+0,95%		-3,64%	+42,47%

16/04	Nightingale Health gaat een laboratorium openen in de Verenigde Staten	CI
16/04	Nightingale Health en het Englander Institute for Precision Medicine van Weill Cornell Medicine tekenen een intentieverklaring waarin de partijen overeenkomen samen te werken aan de toepassing van Nightingale Health's gepatenteerde technologie in de gezondheidszorg en medisch onderzoek in de Verenigde Staten.	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Inside information: Nightingale Health achieves one of its business targets for this financial year by winning contracts in medical research with a total contract value of at least EUR 3.2 million	25/04
Finland’s Nightingale Health Plots US Expansion	16/04
Nightingale Health to establish a laboratory in the United States with Weill Cornell Medicine as the first customer	16/04
Nightingale Health to Establish A Laboratory in the United States	16/04
Nightingale Health and the Englander Institute for Precision Medicine At Weill Cornell Medicine Sign A Letter of Intent in Which the Parties Agree to Collaborate on the Adoption of Nightingale Health's Proprietary Technology in Healthcare and Medical Research in the United States	16/04
Nightingale Health Secures Blood Analysis Contract with Kaiser Foundation	12/04
Supplement to the release: Inside Information: Nightingale Health enters into agreement to analyze 50,000 blood samples with Kaiser Foundation Health Plan, Inc.	12/04
Inside Information: Nightingale Health enters into agreement to analyze 50,000 blood samples with Kaiser Foundation Health Plan, Inc.	12/04
Nightingale Health Enters into Agreement to Analyze 50,000 Blood Samples with Kaiser Foundation Health Plan, Inc	12/04
Nightingale Health Closes Purchase of Japan's Welltus	29/03
Nightingale Health has completed the acquisition of Welltus Inc	29/03
Nightingale Health Oyj completed the acquisition of Welltus Inc from Mitsui & Co., Ltd. and Kirin Holdings Company, Limited.	29/03
Conversion of Nightingale Health Plc's EMP shares to Series B shares	20/03
Nightingale Health's technology used to analyze Uganda's General Population Cohort (GPC)	19/03
Nightingale Health plc Enters into an Agreement in Which It Will Analyze Blood Samples from Uganda's General Population Cohort	19/03
Finland-based Nightingale Health to Buy Japan's Welltus	07/03
Supplement to the release: Inside information: Nightingale Health strengthens its Japan business by acquiring Welltus Inc	07/03
Inside information: Nightingale Health strengthens its Japan business by acquiring Welltus Inc	07/03
Nightingale Health's Half-year report: Healthcare implementations progressing in Finland and Singapore	07/03
Nightingale Health Oyj Reports Earnings Results for the Half Year Ended December 30, 2023	07/03

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Nightingale Health Oyj

Aandelen

HEALTH

FI4000490875

Andere talen

Filters